ReviewGynecology and pelvic medicine2026
The effects of intrauterine devices on anti-Mullerian hormone levels-a mini-review.
Review in Gynecology and pelvic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intrauterine devices (IUDs) are contraceptive devices utilized by many women, especially those who struggle with the use of oral contraceptives. As the age of childbearing rises, it is crucial to have reliable assessments of ovarian reserve, such as anti-Müllerian hormone (AMH) levels. In efforts to provide clinicians with optimal knowledge in the evaluation of fertility, this review investigates the relationship between IUDs and AMH levels. A detailed search of PubMed articles was conducted with six relevant articles discovered. Hormonal IUDs have been shown to either decrease or have no significant impact on AMH levels, while copper IUDs consistently demonstrated no significant effect on AMH levels across all studies. When considering those with heavy menstrual bleeding (HMB), the implementation of hormonal IUDs was associated with a significant increase in AMH levels compared to the cohort's initial values, as well as the controls. The duration of IUD usage was also found to be positively correlated with AMH levels in some studies. Due to the sparsity of studies investigating this correlation, it is difficult to conclude any definitive findings. Future studies should consider differentiating types of hormonal IUDs when studying AMH levels, as well as diversifying the population under investigation to ensure the results are more generalizable. Subpopulations, such as patients with HMB, should continue to be examined as IUDs may impact AMH levels differently than what is typically seen in patients using IUDs exclusively for contraception.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.